Dashboard
Manage Tickers

TXG 10x Genomics, Inc.

Nasdaq 10xgenomics.com


$ 13.76 $ 1.20 (9.65 %)    

Friday, 31-Oct-2025 18:40:45 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 13.64
$ 12.56
$ 12.12 x 1
$ 13.80 x 1
$ 12.44 - $ 13.85
$ 6.78 - $ 18.21
2,614,158
na
1.7B
$ 2.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-12-2025 12-31-2024 10-K
4 10-29-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 04-30-2024 03-31-2024 10-Q
7 02-15-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-16-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-18-2022 12-31-2021 10-K
16 11-05-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-07-2021 03-31-2021 10-Q
19 02-26-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-12-2020 06-30-2020 10-Q
22 05-12-2020 03-31-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

10x-genomics-rolls-out-flex-assay-to-offer-cost-effective-single-cell-analysis
10x Genomics Rolls Out Flex Assay To Offer...
10/29/2025 13:03:59

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of the next generatio...

analyst-expectations-for-10x-genomicss-future
Analyst Expectations For 10x Genomics's Fu...
10/23/2025 19:01:01

Core News & Articles
10x Genomics And Anthropic Announce A Coll...
10/20/2025 16:32:36

Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applicat...

cathie-wood-warns-wall-street-is-missing-ais-biggest-opportunity-in-healthcare-calling-it-sleeper-investment-poised-for-massive-returns
Cathie Wood Warns Wall Street Is Missing A...
10/15/2025 10:17:49

Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its p...

my-top-biotech-stock-picks-and-portfolio-strategy-for-the-next-3-10-years
My Top Biotech Stock Picks And Portfolio S...
09/18/2025 17:10:48

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of...

expert-outlook-10x-genomics-through-the-eyes-of-6-analysts
Expert Outlook: 10x Genomics Through The E...
09/11/2025 12:01:59

this-eaton-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday
This Eaton Analyst Begins Coverage On A Bu...
09/11/2025 11:54:09

piper-sandler-initiates-coverage-on-10x-genomics-with-neutral-rating-announces-price-target-of-15
Piper Sandler Initiates Coverage On 10x Ge...
09/11/2025 11:23:17

Piper Sandler analyst David Westenberg initiates coverage on 10x Genomics (NASDAQ:TXG) with a Neutral rating and announces P...

10x-genomics-and-cliseq-announce-translational-research-collaboration-for-single-cell-applications-in-hematology-clinical-diagnostics
10x Genomics And CLISEQ Announce Translati...
09/09/2025 13:05:45

10x-genomics-launches-xenium-protein
10x Genomics Launches Xenium Protein
08/19/2025 13:13:21

First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deepe...

morgan-stanley-maintains-overweight-on-10x-genomics-lowers-price-target-to-17
Morgan Stanley Maintains Overweight on 10x...
08/12/2025 12:17:05

Morgan Stanley analyst Tejas Savant maintains 10x Genomics (NASDAQ:TXG) with a Overweight and lowers the price target from $...

ubs-maintains-neutral-on-10x-genomics-raises-price-target-to-13
UBS Maintains Neutral on 10x Genomics, Rai...
08/08/2025 18:20:50

UBS analyst Dan Leonard maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from $12 to $13.

analyst-expectations-for-10x-genomicss-future
Analyst Expectations For 10x Genomics's Fu...
08/08/2025 14:01:08

barclays-maintains-overweight-on-10x-genomics-raises-price-target-to-15
Barclays Maintains Overweight on 10x Genom...
08/08/2025 12:47:19

Barclays analyst Luke Sergott maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $13 to ...

10x-genomics-announces-that-it-has-signed-a-definitive-agreement-to-acquire-scale-biosciences-terms-not-disclosed
10x Genomics Announces That It Has Signed ...
08/07/2025 20:49:15

 10x Genomics, Inc. (NASDAQ:TXG), a leader in single cell and spatial biology, today announced that it has signed a definitive ...

10x-genomics-sees-q3-sales-140000m-144000m-vs-143607m-est
10x Genomics Sees Q3 Sales $140.000M-$144....
08/07/2025 20:15:53

10x Genomics (NASDAQ:TXG) sees Q3 sales of $140.000 million-$144.000 million vs $143.607 million analyst estimate.

10x-genomics-q2-eps-028-beats-036-estimate-sales-172900m-beat-139408m-estimate
10x Genomics Q2 EPS $0.28 Beats $(0.36) Es...
08/07/2025 20:15:13

10x Genomics (NASDAQ:TXG) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $(0.36) b...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

b-of-a-securities-maintains-neutral-on-10x-genomics-raises-price-target-to-13
B of A Securities Maintains Neutral on 10x...
06/26/2025 17:57:43

B of A Securities analyst Derik De Bruin maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from...

demystifying-10x-genomics-insights-from-8-analyst-reviews
Demystifying 10x Genomics: Insights From 8...
06/24/2025 19:00:30

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION